GLS1 Inhibitor
- $32 - $201
- Product name: GLS1 Inhibitor
- CAS: 1832646-52-2
- MF: C19H21N7O2S
- MW: 411.48
- EINECS:
- MDL Number:
- Synonyms:4-thiadiazol-2-yl]-benzeneacetamide;αS-methoxy-N-[5-[[(3R)-1-(3-pyridazinyl)-3-pyrrolidinyl]amino]-1;ΑS-METHOXY-N-[5-[[(3R)-1-(3-PYRIDAZINYL)-3-PYRROLIDINYL]AMINO]-1;3;4-THIADIAZOL-2-YL]-BENZENEACETAMIDE;Benzeneacetamide, α-methoxy-N-[5-[[(3R)-1-(3-pyridazinyl)-3-pyrrolidinyl]amino]-1,3,4-thiadiazol-2-yl]-, (αS)-;GLS1 Inhibitor,GLS-1 Inhibitor
4 prices
Selected condition:
Brand
- AK Scientific
- Cayman Chemical
Package
- 1mg
- 5mg
- 10mg
- ManufacturerAK Scientific
- Product number4134ED
- Product descriptionCID100951644
- Packaging5mg
- Price$201
- Updated2021-12-16
- Buy
- ManufacturerCayman Chemical
- Product number28581
- Product descriptionGLS1 Inhibitor
- Packaging10mg
- Price$139
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number28581
- Product descriptionGLS1 Inhibitor
- Packaging5mg
- Price$93
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number28581
- Product descriptionGLS1 Inhibitor
- Packaging1mg
- Price$32
- Updated2024-03-01
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 4134ED | CID100951644 | 5mg | $201 | 2021-12-16 | Buy |
Cayman Chemical | 28581 | GLS1 Inhibitor | 10mg | $139 | 2024-03-01 | Buy |
Cayman Chemical | 28581 | GLS1 Inhibitor | 5mg | $93 | 2024-03-01 | Buy |
Cayman Chemical | 28581 | GLS1 Inhibitor | 1mg | $32 | 2024-03-01 | Buy |
Properties
Density :1.425±0.06 g/cm3(Predicted)
storage temp. :Store at -20°C
solubility :DMF: 20 mg/ml,DMSO: 20 mg/ml,DMSO:PBS (pH 7.2) (1:3): 0.25 mg/ml
form :A crystalline solid
pka :7.42±0.50(Predicted)
storage temp. :Store at -20°C
solubility :DMF: 20 mg/ml,DMSO: 20 mg/ml,DMSO:PBS (pH 7.2) (1:3): 0.25 mg/ml
form :A crystalline solid
pka :7.42±0.50(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|